Aker BioMarine has shared data suggesting krill oil’s share of the omega-3 market increased from 12% in 2012 to 20% in 2016.
Photo © iStockphoto.com/Tenedos
Krill oil’s share of the omega-3 market has increased significantly in recent years, according to new sales figures shared by Aker BioMarine (Oslo, Norway). Between 2012 and 2016, krill oil’s share of the omega-3 market increased from 12% to 20%, Aker says.
Also during the past four years, consumer awareness of krill oil among omega-3 users rose from 20% in 2012 to nearly 50% in 2016. Aker pointed out that while other segments of the omega-3 market contracted during the same period, these figures give Aker reason to believe “the best days for krill oil are ahead.”
What’s more, with a revenue of $105 million last year, Aker called 2015 an historic year that marked “its most exciting growth phase since launching the original Superba krill oil several years ago.”
“In 2015, we set a clear course for our passionate and capable organization,” said Matts Johansen, CEO of Aker BioMarine, in the announcement. “We started this journey to walk the talk by driving change in our culture, simplifying business processes, and aligning our organization towards one common goal and strategy. We aim to be an integral part of our customers’ success. We will continue to drive scientific discovery and innovation and we will further strengthen our product quality and cost leadership in the Antarctic krill supply chain.”
Read more:
Aker’s New Krill Oil Technology Improves Odor, Taste, and Nutritional Profile
Why Krill Oil Is More Stable than Fish Oil
Krill Oil Offers Higher Omega-3 Bioavailability than Fish Oil, Krill Meal, Study Suggests
Michael Crane
Associate Editor
Nutritional Outlook Magazine
michael.crane@ubm.com
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.
2 Commerce Drive
Cranbury, NJ 08512